85 related articles for article (PubMed ID: 23376066)
1. Inhibition of S6K1 enhances glucose deprivation-induced cell death via downregulation of anti-apoptotic proteins in MCF-7 breast cancer cells.
Choi HN; Jin HO; Kim JH; Hong SE; Kim HA; Kim EK; Lee JK; Park IC; Noh WC
Biochem Biophys Res Commun; 2013 Mar; 432(1):123-8. PubMed ID: 23376066
[TBL] [Abstract][Full Text] [Related]
2. S6K1 inhibition enhances tamoxifen-induced cell death in MCF-7 cells through translational inhibition of Mcl-1 and survivin.
Hong SE; Kim EK; Jin HO; Kim HA; Lee JK; Koh JS; Seol H; Kim JI; Park IC; Noh WC
Cell Biol Toxicol; 2013 Aug; 29(4):273-82. PubMed ID: 23942996
[TBL] [Abstract][Full Text] [Related]
3. Effects of sorafenib on energy metabolism in breast cancer cells: role of AMPK-mTORC1 signaling.
Fumarola C; Caffarra C; La Monica S; Galetti M; Alfieri RR; Cavazzoni A; Galvani E; Generali D; Petronini PG; Bonelli MA
Breast Cancer Res Treat; 2013 Aug; 141(1):67-78. PubMed ID: 23963659
[TBL] [Abstract][Full Text] [Related]
4. Embelin inhibits growth and induces apoptosis through the suppression of Akt/mTOR/S6K1 signaling cascades.
Kim SW; Kim SM; Bae H; Nam D; Lee JH; Lee SG; Shim BS; Kim SH; Ahn KS; Choi SH; Sethi G; Ahn KS
Prostate; 2013 Feb; 73(3):296-305. PubMed ID: 22887478
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of S6K1 enhances dichloroacetate-induced cell death.
Hong SE; Shin KS; Lee YH; Seo SK; Yun SM; Choe TB; Kim HA; Kim EK; Noh WC; Kim JI; Hwang CS; Lee JK; Hwang SG; Jin HO; Park IC
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1171-9. PubMed ID: 25471732
[TBL] [Abstract][Full Text] [Related]
6. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S
J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258
[TBL] [Abstract][Full Text] [Related]
7. Sustained antitumor activity by co-targeting mTOR and the microtubule with temsirolimus/vinblastine combination in hepatocellular carcinoma.
Zhou Q; Lui VW; Lau CP; Cheng SH; Ng MH; Cai Y; Chan SL; Yeo W
Biochem Pharmacol; 2012 May; 83(9):1146-58. PubMed ID: 22285225
[TBL] [Abstract][Full Text] [Related]
8. Sorafenib induces apoptotic cell death in human non-small cell lung cancer cells by down-regulating mammalian target of rapamycin (mTOR)-dependent survivin expression.
Kim YS; Jin HO; Seo SK; Woo SH; Choe TB; An S; Hong SI; Lee SJ; Lee KH; Park IC
Biochem Pharmacol; 2011 Aug; 82(3):216-26. PubMed ID: 21601561
[TBL] [Abstract][Full Text] [Related]
9. p70 S6K1 nuclear localization depends on its mTOR-mediated phosphorylation at T389, but not on its kinase activity towards S6.
Rosner M; Schipany K; Hengstschläger M
Amino Acids; 2012 Jun; 42(6):2251-6. PubMed ID: 21710263
[TBL] [Abstract][Full Text] [Related]
10. S6 kinase 2 promotes breast cancer cell survival via Akt.
Sridharan S; Basu A
Cancer Res; 2011 Apr; 71(7):2590-9. PubMed ID: 21427355
[TBL] [Abstract][Full Text] [Related]
11. Harmol induces autophagy and subsequent apoptosis in U251MG human glioma cells through the downregulation of survivin.
Abe A; Kokuba H
Oncol Rep; 2013 Apr; 29(4):1333-42. PubMed ID: 23338618
[TBL] [Abstract][Full Text] [Related]
12. Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification.
Tanizaki J; Okamoto I; Fumita S; Okamoto W; Nishio K; Nakagawa K
Oncogene; 2011 Sep; 30(39):4097-106. PubMed ID: 21499301
[TBL] [Abstract][Full Text] [Related]
13. Cyclic GMP/protein kinase G type-Iα (PKG-Iα) signaling pathway promotes CREB phosphorylation and maintains higher c-IAP1, livin, survivin, and Mcl-1 expression and the inhibition of PKG-Iα kinase activity synergizes with cisplatin in non-small cell lung cancer cells.
Wong JC; Bathina M; Fiscus RR
J Cell Biochem; 2012 Nov; 113(11):3587-98. PubMed ID: 22740515
[TBL] [Abstract][Full Text] [Related]
14. Evodiamine induces apoptosis and enhances TRAIL-induced apoptosis in human bladder cancer cells through mTOR/S6K1-mediated downregulation of Mcl-1.
Zhang T; Qu S; Shi Q; He D; Jin X
Int J Mol Sci; 2014 Feb; 15(2):3154-71. PubMed ID: 24566141
[TBL] [Abstract][Full Text] [Related]
15. Rationally designed aberrant kinase-targeted endogenous protein nanomedicine against oncogene mutated/amplified refractory chronic myeloid leukemia.
Retnakumari AP; Hanumanthu PL; Malarvizhi GL; Prabhu R; Sidharthan N; Thampi MV; Menon D; Mony U; Menon K; Keechilat P; Nair S; Koyakutty M
Mol Pharm; 2012 Nov; 9(11):3062-78. PubMed ID: 22971013
[TBL] [Abstract][Full Text] [Related]
16. Characterization of PF-4708671, a novel and highly specific inhibitor of p70 ribosomal S6 kinase (S6K1).
Pearce LR; Alton GR; Richter DT; Kath JC; Lingardo L; Chapman J; Hwang C; Alessi DR
Biochem J; 2010 Oct; 431(2):245-55. PubMed ID: 20704563
[TBL] [Abstract][Full Text] [Related]
17. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
[TBL] [Abstract][Full Text] [Related]
18. Decreased glycolytic metabolism contributes to but is not the inducer of apoptosis following IL-3-starvation.
Gonin-Giraud S; Mathieu AL; Diocou S; Tomkowiak M; Delorme G; Marvel J
Cell Death Differ; 2002 Oct; 9(10):1147-57. PubMed ID: 12232803
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells.
Mandal M; Kumar R
Cell Growth Differ; 1996 Mar; 7(3):311-8. PubMed ID: 8838861
[TBL] [Abstract][Full Text] [Related]
20. Butyrate inhibits the proliferation and induces the apoptosis of colorectal cancer HCT116 cells via the deactivation of mTOR/S6K1 signaling mediated partly by SIRT1 downregulation.
Cao M; Zhang Z; Han S; Lu X
Mol Med Rep; 2019 May; 19(5):3941-3947. PubMed ID: 30864709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
